You are here

PancreasCHIP - A diagnostic tool for Inheritable Pancreatic Disease

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DK105640-01
Agency Tracking Number: R43DK105640
Amount: $266,046.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: 300
Solicitation Number: PA14-071
Solicitation Year: 2015
Award Year: 2015
Award Start Date (Proposal Award Date): 2015-03-01
Award End Date (Contract End Date): 2017-02-28
Small Business Information
10101 Alliance Rd
Cincinnati, OH 45242-4739
United States
DUNS: 182472162
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (513) 475-6618
Business Contact
Phone: (513) 475-6618
Research Institution

DESCRIPTION provided by applicant Pancreatitis is a painful condition that may become recurrent or chronic in genetically susceptible individuals Patients with pancreatitis suffer multiple hospital admissions pain episodes addiction to pain medications and psychosocial stressors by missing school by the child and work by family members As an important underlying etiology of pancreatitis genetic factors are becoming an integral component of diagnostic algorithms In order to translate recent advances into opportunities to improve clinical
care we propose to develop a high throughput gene chip that identifies mutations in the genes that cause the most common forms of inherited syndromes of pancreatitis In this Phase I application we will test the technical merit of a gene sequencing platform that is customized to patients with pancreatitis which we call the PancreasCHIP Our Specific Aim in this Phase I application is to determine the accuracy of the PancreasCHIP to sequence the target genes We will pursue this aim by testing two hypotheses First we hypothesize that the PancreasCHIP sequences the target genes at andgt accuracy In preliminary studies we analyzed the nucleotide composition of the target genes and designed a one step TruSeq multiplex platform to generate amplicons for all exons and target intron exon boundaries with andgt coverage We will generate amplicons in healthy subjects serving as controls and compare chip readouts with known sequences Second we hypothesize that the PancreasCHIP identifies mutations in patients with pancreatitis To this end we will examine whether the sequence output produced by the PancreasCHIP detects insertions deletions or indels in DNA of patients with chronic familial pancreatitis Collectively these experiments will validate the technical merits of PancreasCHIP and will position us for future experiments to further bench test the assay and develop an automated detection algorithm in a future Phase II application Ultimately our goal is to bring the customized sequencing platform to full use in the clinic to readily facilitate diagnostics and personalized care of patients with pancreatic diseases

PUBLIC HEALTH RELEVANCE Pancreatic disease is common in children and adults Pancreatitis is an inflammation of the pancreas that leads to either a one time attack or in a subset of cases to recurrent attacks that lead to multiple hospital admissions and painful episodes Pancreatitis is a burden on patients families as well as the society with health care expenses ongoing pain issues and lost time from school or work We propose to design a gene chip for the evaluation of the genetic cause of pancreatitis This grant application will develop and determine the technical merit of the andquot PancreasCHIPandquot as a mutation screening tool that will look for mutations in the six genes known to cause this disease simultaneously When fully validated the chip will cut the cost and decrease the wait time for genetic testing results

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government